Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001185732 | SCV001351998 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001460719 | SCV001664598 | likely benign | Juvenile polyposis syndrome | 2024-07-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001185732 | SCV002662984 | likely benign | Hereditary cancer-predisposing syndrome | 2020-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001460719 | SCV004842881 | likely benign | Juvenile polyposis syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV001460719 | SCV005407077 | benign | Juvenile polyposis syndrome | 2024-08-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |